SOTYKTU

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Finland, France, Ireland, Italy, Japan, Lithuania, Romania, United Kingdom, United States

Active ingredients

The drug SOTYKTU contains one active pharmaceutical ingredient (API):

1 Deucravacitinib UNII N0A21N6RAU - DEUCRAVACITINIB

Deucravacitinib selectively inhibits the TYK2 enzyme (TYK2 belongs to the JAK family). TYK2 mediates signalling of interleukin-23 (IL-23), interleukin-12 (IL-12), and type I interferons (IFN), which are naturally occurring cytokines involved in inflammatory and immune responses. Deucravacitinib inhibits the release of proinflammatory cytokines and chemokines. Read about Deucravacitinib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOTYKTU Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AF07		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AF Janus-associated kinase (JAK) inhibitors
Discover more medicines within L04AF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02533030
Country: EE	Ravimiamet	Identifier(s): 3038150, 3038161, 3038172, 3038183
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 573217
Country: FR	Base de données publique des médicaments	Identifier(s): 69187374
Country: IT	Agenzia del Farmaco	Identifier(s): 050635010, 050635022, 050635034, 050635046, 050635059, 050635061, 050635073, 050635085
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999057F1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1096915, 1096916, 1096917, 1096918, 1096919, 1096920, 1096921, 1096922
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69691001, W69691002
Country: US	FDA, National Drug Code	Identifier(s): 0003-0895